|
TRAX First Tracks Biotherapeutics Inc 2091349 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-50,484,000.00 |
| Balance Sheet |
|
Current Assets
|
$289,402,000.00 |
|
Assets
|
$290,576,000.00 |
|
Current Liabilities
|
$33,112,000.00 |
|
Equity
|
$257,464,000.00 |
|
Shares Out
|
34892381.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-32,561,000.00 |
|
Investing Cash Flow
|
$34,983,000.00 |
| Market Analysis |
Market Cap
|
$1,667,157,964.18 |
|
Price
|
$44.38 |
|
BVPS
|
7.38 |
|
PB
|
6.47 |
|
FCF
|
$-32,578,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRAX documents filed with the SEC.
TRAX Filings
Clear
